Kindred Biosciences, Inc.
KIN
KIN was delisted on the 27th of August, 2021.
75 hedge funds and large institutions have $233M invested in Kindred Biosciences, Inc. in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 16 reducing their positions, and 10 closing their positions.
106% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 16
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
4% more funds holding
Funds holding: 72 → 75 (+3)
4% less capital invested
Capital invested by funds: $242M → $233M (-$8.65M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$8.05M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$7.53M |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
+$6.31M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.25M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$4.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$6.98M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$1.63M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.16M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.08M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.06M |
KIN Hedge Fund Activity: Q1 2019 in Review
75 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q1 2019, worth a combined $233M — down 3.6% from $242M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new KIN positions and 10 closed out — a net gain of 3 holders — while 33 added to existing stakes and 16 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $8.05M. The largest seller was Morgan Stanley, cutting an estimated $6.98M.
- 75 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q1 2019, up from 72 in Q4 2018.
- Funds reported $233M of Kindred Biosciences, Inc. stock for Q1 2019, down 3.6% quarter-over-quarter.
- 13 funds opened new Kindred Biosciences, Inc. positions in Q1 2019 and 10 closed out, a net change of +3 holders.
- The largest Kindred Biosciences, Inc. buyer in Q1 2019 was Deutsche Bank, an estimated $8.05M added.
- The largest Kindred Biosciences, Inc. seller in Q1 2019 was Morgan Stanley, an estimated $6.98M sold.
Based on aggregated 13F filings for Q1 2019.